CardiAction
This could be the most important 20 minutes of your life
Book Your CardiAction Heart Screening Today.
Unichem Havelock North have trained, friendly staff ready to assist you with your next Heart Screening. CardiAction is an innovative heart screening and intervention management app to make heart and artery health easy to improve and manage.
The Details
Cardiovascular disease (CVD) is the leading cause of death for both men and women in New Zealand, claiming a life every 90 minutes. Chances are, you or someone you love could be at risk—often without even knowing it.The good news? Up to 80% of premature CVD cases are preventable. Our non-invasive, pain-free screening gives you a personalised heart health assessment, helping you understand your risks and take control of your wellbeing.
At Health Screening NZ, we use the Uscom BP+, a cutting-edge device transforming hypertensive care and cardiovascular risk assessment. This FDA and TGA-approved Pulse Wave Analysis (PWA) device is trusted by healthcare professionals in clinical research and general practice.With the Uscom BP+, we offer accurate, non-invasive cardiovascular screenings as part of our CardiAction service, helping you take control of your heart health with confidence.
The Cardiaction heart screening assesses key indicators of cardiovascular health, including arterial stiffness, central systolic pressure, and heart function. Using these insights, we provide personalised, science-backed lifestyle recommendations, all accessible through the Cardiaction app. A quick, non-invasive PWA test offers a comprehensive heart health overview, with annual check-ups recommended to stay proactive.
The screening service costs $99. Health Screening NZ, the service provider, sets the pricing.
Screeners are selected and trained by Health Screening NZ. They receive operational training under the supervision of Health Screening NZ’s team. However, screeners are not licensed healthcare providers and follow a protocol established by Health Screening NZ. The results of your screening are reviewed by healthcare professionals, but screeners cannot diagnose or discuss any pre-existing conditions. If your CardiAction Risk Indicator score shows elevated risk, you will be encouraged to seek advice from a GP.
Pulse Wave Analysis (PWA) measures the shape of the pulse wave generated by your heart. The test uses the Uscom BP+ machine, a TGA/FDA-approved pulse wave analyser, to assess:
- Central (aortic) heart pressure
- Peripheral (arteries) resistance
- Cardiac efficiency (SEVR)
- Abnormalities in heart rhythm (arrhythmia)
Your results are uploaded to your CardiAction profile on the platform and added to your account in the app if you have downloaded it and set it up. This test is designed to identify increased peripheral resistance, which can indicate inflammation in the arteries.
No, the PWA test is non-invasive and pain-free. It’s similar to having your blood pressure taken with a cuff placed around your arm. We aim to create a stress-free environment to ensure the most accurate results.
If your CardiAction Risk Indicator score shows elevated risk, we strongly advise visiting your GP as soon as possible for a more thorough evaluation. Your GP will be able to conduct additional tests, provide a diagnosis, and recommend appropriate treatment or lifestyle changes.